This inventor holds 1 USPTO granted patent. Top assignees: Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik', Institut Elementoorganicheskikh Soedineny Rossiiskoi Akademii Nauk, Moskovsky Naucho-Issledovatelsky Onkologichesky Institut. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: **Anatoly Borisovich Syrkin: A Pioneer in Tumor Suppression**
Introduction
Anatoly Borisovich Syrkin, a distinguished inventor based in Moscow, Russia, has made notable contributions to medical science through his innovative approach to cancer treatment. With a focus on tumor growth suppression, his work is critical in addressing one of the most pressing health challenges of our time.
Latest Patents
Syrkin holds a patent for an "Agent for Suppressing Tumor Growth," which represents a significant advancement in therapeutic strategies aimed at cancer. This innovation reflects his commitment to improving patient outcomes and his expertise in the field of medical research.
Career Highlights
During his career, Syrkin has worked with prominent institutions such as the Institute of Elemento-organic Compounds of the Russian Academy of Sciences and the State Scientific Center of the Russian Federation "NIOPIK." His association with these organizations underscores his involvement in critical research and the development of groundbreaking medical treatments.
Collaborations
Syrkin has collaborated with eminent colleagues, including Mark Efimovich Volpin and Georgy Nikolaevich Vorozhtsov. These relationships have facilitated a rich exchange of ideas and innovations, further enhancing the impact of his work in cancer research and treatment.
Conclusion
Anatoly Borisovich Syrkin exemplifies the spirit of innovation in the field of medical science. Through his patents and collaboration with esteemed institutions and fellow researchers, he plays a vital role in the ongoing fight against cancer, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile